Novel Drug Delivery Systems (NDDS) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Novel Drug Delivery Systems in cancer therapy market size was valued at USD 4.31 billion in 2016 and is projected to grow at a CAGR of 22% during the forecast period 2021-2027.

The new drug delivery system (NDDS) is an approach, technology, and formulation for delivering drugs into the body. This includes targeting scientific sites inside the body. This new system helps reduce drug breakdown, increases drug availability, and prevents harmful side effects of drugs. In addition, the system offers a variety of commercial and therapeutic benefits by formulating new drug delivery devices to enable the integration of drug molecules into new delivery systems.

Market Segments

By Route of Administration
• Oral Drug Delivery Systems
• Injectable Drug Delivery Systems
• Pulmonary Drug Delivery Systems
• Transdermal Drug Delivery Systems
• Others

By Mode of NDDS
• Targeted Drug Delivery Systems
• Controlled Drug Delivery Systems
• Modulated Drug Delivery Systems

Key Players

Some of the market players are Abbott Laboratories, AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi SA

Scope of the Report

The research study analyzes the global Novel Drug Delivery Systems (NDDS) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Novel Drug Delivery Systems (NDDS) Market Report

1. What was the Novel Drug Delivery Systems (NDDS) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Novel Drug Delivery Systems (NDDS) Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Novel Drug Delivery Systems (NDDS) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.